CIPOLLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 908
EU - Europa 754
AS - Asia 356
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.024
Nazione #
US - Stati Uniti d'America 908
GB - Regno Unito 338
CN - Cina 302
SE - Svezia 92
IE - Irlanda 75
FR - Francia 72
IT - Italia 71
DE - Germania 39
FI - Finlandia 33
KR - Corea 25
VN - Vietnam 21
BE - Belgio 15
UA - Ucraina 8
AU - Australia 4
CH - Svizzera 3
ES - Italia 2
JP - Giappone 2
NL - Olanda 2
RU - Federazione Russa 2
BO - Bolivia 1
CZ - Repubblica Ceca 1
EU - Europa 1
IL - Israele 1
IN - India 1
KZ - Kazakistan 1
MD - Moldavia 1
SA - Arabia Saudita 1
SG - Singapore 1
TR - Turchia 1
Totale 2.024
Città #
Southend 303
Chandler 266
Woodbridge 91
Ann Arbor 87
Beijing 79
Dublin 75
Jacksonville 58
Ashburn 56
Houston 43
Nanjing 36
Lawrence 29
Princeton 29
Jinan 27
New York 25
Seoul 24
Shenyang 24
Wilmington 21
Hebei 14
Brussels 13
Changsha 13
Helsinki 13
Verona 12
Dong Ket 11
Nanchang 9
Ningbo 9
Taizhou 9
Haikou 8
Sindelfingen 7
Tianjin 7
Ferrara 6
Jiaxing 6
Norwalk 6
Zhengzhou 6
Bologna 5
Falls Church 5
Hangzhou 5
Lanzhou 5
Redwood City 5
Taiyuan 5
Auburn Hills 4
Boardman 4
Milan 4
Seattle 4
Dearborn 3
Dundee 3
Düsseldorf 3
Fuzhou 3
Guangzhou 3
Washington 3
Canberra 2
Dewsbury 2
Kemerovo 2
Lappeenranta 2
Los Angeles 2
Miami 2
Noicattaro 2
Tappahannock 2
Waanrode 2
Almaty 1
Buffalo 1
Böblingen 1
Cambridge 1
Changle 1
Chicago 1
Chions 1
Chisinau 1
Clearwater 1
Costa Mesa 1
Crotone 1
Deptford 1
Donetsk 1
Fairfield 1
Falkenstein 1
Fremont 1
Giovinazzo 1
Kharkov 1
Las Vegas 1
Madrid 1
Mehlingen 1
Nashville 1
Nocera Inferiore 1
Padova 1
Pavia 1
Porto San Giorgio 1
Qingdao 1
Redmond 1
Riyadh 1
San Francisco 1
Sant'Ambrogio di Valpolicella 1
Singapore 1
Sucre 1
Sydney 1
Tel Aviv 1
Tokyo 1
Torino 1
Totale 1.541
Nome #
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. 218
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. 100
Further characterization of Shwachman-Diamond syndrome: psychological functioning and quality of life in adult and young patients. 100
Further Insights into the Hematological Disorders Observed in Shwachman-Diamond Syndrome: mTOR and STAT3 Hyper-Phosphorylation in CD4+ and CD8+ T Cells and Efficacy of Rapamycin Treatment 92
Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. 90
Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. 86
Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome 76
Ataluren-driven Restoration of Shwachman-Bodian-Diamond Syndrome Protein Function in Shwachman-Diamond Syndrome Bone Marrow Cells 74
Identification of novel mutations in patients with Shwachman-Diamond syndrome 74
Shwachman-Diamond syndrome 73
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome 70
Mutation Screening of Elongation Factor 2 in Shwachman-Diamond Syndrome Patients Lacking Mutations in the SBDS Gene 67
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 65
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 61
GENETIC ANALYSIS OF THE SBDS GENE AMONG NON-ITALIAN PATIENTS 59
A Prospective Haematological Survey Of Italian Patients Affected By Shwachman-Diamond Syndrome: Results Of A Ten Years Multicentric Study 57
291 Colon cancer screening program in adult CF patients: an Italian cross-sectional pilot study 56
Celiac disease and obesity: need for nutritional follow-up after diagnosis. 54
Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability 54
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 54
Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old 53
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 52
A Prospective Study of Hematologic Complications and Long-Term Survival of Italian Patients Affected by Shwachman-Diamond Syndrome 48
null 46
Novel Translational Read-Through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome 44
Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients 42
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 39
Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond Syndrome carrying biallelic SBDS mutations 38
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes 33
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 26
The Gluten Free Diet's Impact on Growth in Children with Celiac Disease in Two Different Countries 22
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 17
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 13
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 11
Efficacy of Elexacaftor–Tezacaftor–Ivacaftor on chronic rhinosinusitis in cystic fibrosis 4
Totale 2.068
Categoria #
all - tutte 6.655
article - articoli 6.092
book - libri 0
conference - conferenze 563
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 7 1 5
2019/2020222 36 1 3 10 33 10 31 7 23 32 16 20
2020/2021243 49 32 26 30 18 17 4 10 2 5 23 27
2021/2022211 11 75 1 11 7 3 4 15 7 6 17 54
2022/2023616 33 84 43 126 50 140 4 32 71 8 15 10
2023/2024249 10 23 21 37 33 47 12 32 7 27 0 0
Totale 2.068